ALK and neoplasm: Pretreatment and post‐treatment resistant tumor samples from EGFR‐mutant or ALK‐positive patients demonstrate that SCLC transformation is one of the resistance mechanisms leading to tumor histological changes and independence from the original signaling axis [62, 63, 64].